title: Chronic myeloid leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
authors.affiliation: Department of Hematology-Oncology L and A. Seràgnoli, University of Bologna, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Baccarani
authors.forename: S
authors.initials: S
authors.lastname: Pileri
authors.forename: J-L
authors.initials: JL
authors.lastname: Steegmann
authors.forename: M
authors.initials: M
authors.lastname: Muller
authors.forename: S
authors.initials: S
authors.lastname: Soverini
authors.forename: M
authors.initials: M
authors.lastname: Dreyling
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D019468:Disease Management; D019008:Drug Resistance, Neoplasm; D016313:Genes, abl; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis* / Q000188:drug therapy* / Q000235:genetics; D058990:Molecular Targeted Therapy; D011379:Prognosis; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D012306:Risk; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors